| The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo … C Baigent, MJ Landray, C Reith, J Emberson, DC Wheeler, C Tomson, ... The Lancet 377 (9784), 2181-2192, 2011 | 2927 | 2011 |
| Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease D De Zeeuw, T Akizawa, P Audhya, GL Bakris, M Chin, H Christ-Schmidt, ... New England Journal of Medicine 369 (26), 2492-2503, 2013 | 1032 | 2013 |
| A randomized, controlled trial of early versus late initiation of dialysis BA Cooper, P Branley, L Bulfone, JF Collins, JC Craig, MB Fraenkel, ... New England Journal of Medicine 363 (7), 609-619, 2010 | 1019 | 2010 |
| Burden of care and quality of life among caregivers for adults receiving maintenance dialysis: a systematic review EL Gilbertson, R Krishnasamy, C Foote, AL Kennard, MJ Jardine, ... American Journal of Kidney Diseases 73 (3), 332-343, 2019 | 168 | 2019 |
| Barriers to timely arteriovenous fistula creation: a study of providers and patients PA Lopez-Vargas, JC Craig, MP Gallagher, RG Walker, PL Snelling, ... American journal of kidney diseases 57 (6), 873-882, 2011 | 105 | 2011 |
| The impact of automated eGFR reporting and education on nephrology service referrals E Noble, DW Johnson, N Gray, P Hollett, CM Hawley, SB Campbell, ... Nephrology Dialysis Transplantation 23 (12), 3845-3850, 2008 | 98 | 2008 |
| A trial of extending hemodialysis hours and quality of life GSM Jardine MJ, Zuo L, Gray NA, de Zoysa JR, Chan CT, Gallagher MP, Monaghan H Journal of the American Society of Nephrology 28 (6), 1898-1911, 2017 | 80 | 2017 |
| Outcomes of extended-hours hemodialysis performed predominantly at home M Jun, MJ Jardine, N Gray, R Masterson, PG Kerr, JWM Agar, CM Hawley, ... American journal of kidney diseases 61 (2), 247-253, 2013 | 71 | 2013 |
| Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial HJL Heerspink, J Radhakrishnan, CE Alpers, J Barratt, S Bieler, U Diva, ... The Lancet 401 (10388), 1584-1594, 2023 | 70 | 2023 |
| Conservative management and end-of-life care in an Australian cohort with ESRD RL Morton, AC Webster, K McGeechan, K Howard, FEM Murtagh, ... Clinical Journal of the American Society of Nephrology 11 (12), 2195-2203, 2016 | 68 | 2016 |
| Renal replacement therapy in rural and urban Australia NA Gray, H Dent, SP McDonald Nephrology Dialysis Transplantation 27 (5), 2069-2076, 2012 | 50 | 2012 |
| Socioeconomic differences in the uptake of home dialysis BS Grace, PA Clayton, NA Gray, SP McDonald Clinical Journal of the American Society of Nephrology 9 (5), 929-935, 2014 | 45 | 2014 |
| Patient kidney disease knowledge remains inadequate with standard nephrology outpatient care NA Gray, JJ Kapojos, MT Burke, C Sammartino, CJ Clark Clinical Kidney Journal 9, 113-118, 2016 | 41 | 2016 |
| Unique X-linked familial FSGS with co-segregating heart block disorder is associated with a mutation in the NXF5 gene T Esposito, RA Lea, BH Maher, D Moses, HC Cox, S Magliocca, A Angius, ... Human Molecular Genetics 22 (18), 3654-3666, 2013 | 38 | 2013 |
| Peritoneal dialysis in rural Australia NA Gray, BS Grace, SP McDonald BMC nephrology 14, 1-8, 2013 | 34 | 2013 |
| Randomized cross‐over comparison of intravenous and subcutaneous darbepoetin dosing efficiency in haemodialysis patients MJ Cervelli, N Gray, S McDonald, MG Gentgall, APS Disney Nephrology 10 (2), 129-135, 2005 | 34 | 2005 |
| Data quality of the a ustralia and N ew Z ealand D ialysis and T ransplant R egistry: a pilot audit NA Gray, K Mahadevan, VK Campbell, EP Noble, CM Anstey Nephrology 18 (10), 665-670, 2013 | 32 | 2013 |
| Renal services disaster planning: Lessons learnt from the 2011 Q ueensland floods and N orth Q ueensland cyclone experiences DW Johnson, B Hayes, NA Gray, C Hawley, J Hole, M Mantha Nephrology 18 (1), 41-46, 2013 | 31 | 2013 |
| Kidney disease health literacy among new patients referred to a nephrology outpatient clinic MT Burke, J Kapojos, C Sammartino, NA Gray Internal Medicine Journal 44 (11), 1080-1086, 2014 | 30 | 2014 |
| Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial BH Rovin, J Barratt, HJL Heerspink, CE Alpers, S Bieler, DW Chae, ... The Lancet 402 (10417), 2077-2090, 2023 | 27 | 2023 |
